VANCOUVER, May 12 /CNW/ - Neuromed Technologies Inc., a biopharmaceutical
company developing a new generation of chronic pain drugs, today announced the
appointment of Dr. Barry Sachais to Vice President, Clinical Development,
Mr. Sean Cunliffe to Vice President, Commercial Development and Dr. Simon Li
to Vice President, Medical Research. All three positions are newly created.
